GBP/USD 1.341 ↓ EUR/GBP 0.867 ↓ GBP/JPY 199.094 ↓ EUR/USD 1.162 ↓ GBP/AUD 2.060 ↑ USD/JPY 148.445 ↓ USD/CAD 1.373 ↑ AUD/USD 0.651 ↓ CAD/JPY 108.139 ↓ EUR/CAD 1.595 ↓ GBP/CAD 1.841 ↑ AUD/CAD 0.894 ↓ AUD/JPY 96.641 ↓ AUD/NZD 1.095 ↑ EUR/AUD 1.785 ↓ GBP/USD 1.341 ↓ EUR/GBP 0.867 ↓ GBP/JPY 199.094 ↓ EUR/USD 1.162 ↓ GBP/AUD 2.060 ↑ USD/JPY 148.445 ↓ USD/CAD 1.373 ↑ AUD/USD 0.651 ↓ CAD/JPY 108.139 ↓ EUR/CAD 1.595 ↓ GBP/CAD 1.841 ↑ AUD/CAD 0.894 ↓ AUD/JPY 96.641 ↓ AUD/NZD 1.095 ↑ EUR/AUD 1.785 ↓
CURRENCY .wiki

You’re leaving Currency.Wiki

https://markets.businessinsider.com/news/stocks/kamari-pharma-announces-closing-of-23-million-financing-to-advance-its-first-in-class-oral-trpv3-inhibitor-for-rare-genetic-skin-diseases-1034789582

You’ll be sent to an external site. Currency.Wiki isn’t responsible for privacy or security there. By clicking Continue to Site, you accept these terms. We won’t show this prompt again for 7 days.

Continue to Site